Evidence map›Paper›PMID 24464582›Full record

ArticleThe Journal of biological chemistry2014

c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA.

Md Ashraful Islam, Shelia D Thomas, Vundavalli V Murty, Kara J Sedoris, Donald M Miller

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. The interactions of Pu22 G-quadruplex, derived fromMolecular therapy. Nucleic acids · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. The Connection Between Cell Fate and Telomere.Advances in experimental medicine and biology · 2021
    Review
  10. Folding Landscape of a Parallel G-Quadruplex.The journal of physical chemistry letters · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Telomerase as a Cancer Target. Development of New Molecules.Current topics in medicinal chemistry · 2016
    Review
  17. Article
  18. Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics.International journal of biological sciences · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Md Ashraful IslamFrom the Department of Medicine and Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202 and.
Shelia D Thomas
Vundavalli V Murty
Kara J Sedoris
Donald M Miller
University of Louisville · USColumbia University Irving Medical Center · US

Funding

NIGMS NIH HHS 1P30GM10639601
6 · The paper itself

Abstract

Quadruplex-forming DNA sequences are present throughout the eukaryotic genome, including in telomeric DNA. We have shown that the c-Myc promoter quadruplex-forming sequence Pu-27 selectively kills transformed cells (Sedoris, K. C., Thomas, S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., and Miller, D. M. (2012) Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol. Cancer Ther. 11, 66-76). In this study, we show that Pu-27 induces profound DNA damage, resulting in striking chromosomal abnormalities in the form of chromatid or chromosomal breaks, radial formation, and telomeric DNA loss, which induces γ-H2AX in U937 cells. Pu-27 down-regulates telomeric shelterin proteins, DNA damage response mediators (RAD17 and RAD50), double-stranded break repair molecule 53BP1, G2 checkpoint regulators (CHK1 and CHK2), and anti-apoptosis gene survivin. Interestingly, there are no changes of DNA repair molecules H2AX, BRCA1, and the telomere maintenance gene, hTERT. ΔB-U937, where U937 cells stably transfected with deleted basic domain of TRF2 is partially sensitive to Pu-27 but exhibits no changes in expression of shelterin proteins. However, there is an up-regulation of CHK1, CHK2, H2AX, BRCA1, and survivin. Telomere dysfunction-induced foci assay revealed co-association of TRF1with γ-H2AX in ATM deficient cells, which are differentially sensitive to Pu-27 than ATM proficient cells. Alt (alternating lengthening of telomere) cells are relatively resistant to Pu-27, but there are no significant changes of telomerase activity in both Alt and non-Alt cells. Lastly, we show that this Pu-27-mediated sensitivity is p53-independent. The data therefore support two conclusions. First, Pu-27 induces DNA damage within both telomeric and nontelomeric regions of the genome. Second, Pu-27-mediated telomeric damage is due, at least in part, to compromise of the telomeric shelterin protein complex.

Indexed as

DNA DamageGenes, mycG-QuadruplexesAtaxia Telangiectasia Mutated ProteinsBase SequenceCell DeathCell Line, TumorDNAHistonesHumansNeoplasmsPhosphorylationPromoter Regions, GeneticProto-Oncogene Proteins c-mycShelterin ComplexTelomereAtaxia Telangiectasia Mutated ProteinsDNAH2AX protein, humanHistonesProto-Oncogene Proteins c-mycShelterin ComplexTelomere-Binding ProteinsTumor Suppressor Protein p53Alt CellATMCell DeathDNA DamageG-quadruplexMycPhospho-H2AXShelterinSurvivinTelomeres

Identifiers

PMID24464582
PMCPMC3961676
OpenAlexW2046914695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.